PMID: 9433381Jan 20, 1998Paper

Hodgkin's disease coexisting with myelodysplastic syndrome prior to therapy: a case report and a review of the association of Hodgkin's disease with stem cell disorders

Annals of Hematology
M T Elghetany

Abstract

The myelodysplastic syndromes (MDS) and acute myeloid leukemia (AML) are well-documented complications secondary to chemotherapy and radiation therapy for Hodgkin's disease (HD). The coexistence of primary MDS with HD prior to therapy is an extremely rare event which has been reported only once in the English literature. This is the second case of such combination. Both patients with MDS developed AML only 7 months after diagnosis and both died shortly after the initiation of treatment. Since these cases raise the possibility of a stem cell association with HD, we reviewed the literature for other stem cell disorders with similar association with HD prior to aggressive therapy. Four cases of stem cell disorders other than MDS were reported. These included two cases of aplastic anemia, one case of myeloid metaplasia with myelofibrosis, and one of polycythemia vera. Two of the four patients died, one of AML and the other of thrombocytopenia-related cerebral hemorrhage. The association between HD and stem cell disorders, although rare, may need to be investigated further.

Citations

Sep 9, 2008·Journal of Pediatric Hematology/oncology·Tadashi MatsubayashiJun Miyahara
Jan 7, 2003·Human Pathology·Mahlon D JohnsonPaul L Moots
Jun 11, 2014·American Journal of Hematology·Massimo DozzoRenato Fanin

❮ Previous
Next ❯

Related Concepts

Related Feeds

AML: Role of LSD1 by CRISPR (Keystone)

Find the latest rersearrch on the ability of CRISPR-Cas9 mutagenesis to profile the interactions between lysine-specific histone demethylase 1 (LSD1) and chemical inhibitors in the context of acute myeloid leukemia (AML) here.

Acute Myeloid Leukemia

Acute myeloid leukemia (AML) is a clinically and genetically heterogeneous disease with approximately 20,000 cases per year in the United States. AML also accounts for 15-20% of all childhood acute leukemias, while it is responsible for more than half of the leukemic deaths in these patients. Here is the latest research on this disease.

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.